ŁUKASIEWICZ – PORT / POLISH SCIENCE FUND (19)
| 1 | Coupling of synthesis and transport for proteins targeted to the mitochondia | 1 165 520 PLN | 2014–2018 | Agnieszka Chacińska |
| 2 | Cross-talk between the transport of mitochondrial proteins and cellular protein homeostasis | 4 271 581 PLN | 2016–2021 | Agnieszka Chacińska |
| 3 | Characterization of the TIM23 pathway of protein import into mitochondria in mammalian cells | 1 198 600 PLN | 2016–2019 | Michał Wasilewski |
| 4 | Specific Support Action - Co-ordinated internet-linked networks for promoting innovation, exchanging knowledge and encouraging good practice to enhance bioscience education in European schools, VOLVOX | 38 354 EUR | 2005–2008 | Agnieszka Chołuj |
| 5 | Enabling routine and reliable analysis of transport tunnels in proteins | 1 375 050 PLN | 2018–2021 | Jan Brezovsky |
| 6 | Support for bio tech med. scientists in technology transfer | 2 586 221 PLN | 2010–2013 | Magda Powierża |
| 7 | The impact of intracellular distribution and endocytic transport of lymphotoxin beta receptor (LTbetaR) on its signaling | 996 125 PLN | 2017–2020 | Magdalena Banach-Orłowska |
| 8 | Support for patent procedure of the invention: Tools and methods useful in characterising the immunotoxic activity of xenobiotic substances | 230 315 PLN | 2011–2015 | Magdalena Powierża |
| 9 | Integrated support programme for foreigners at IIMCB | 454 200 PLN | 2019–2022 | Katarzyna Fiedorowicz |
| 10 | Role of dendrtic mRNA transport and local protein syntheis in development of dendritic arbor of neurons | 300 000 PLN | 2007–2010 | Jacek Jaworski |
| 11 | Virtual Research Institute (WIB) – Horizon for Excellence in messenger RNA applications in immunoOncology, HERO | 28 398 800 PLN (IIMCB) | 2022–2027 | Andrzej Dziembowski |
| 12 | The study of genetic variation at the cellular level – new opportunities for forensic identification | 9 904 670 PLN | 2010–2013 | Jacek Kuźnicki |
| 13 | Initial Training Network - Transport and signalling mechanism in polarized cells, TRANSPOL | 225 523 EUR | 2010–2014 | Marta Miączyńska |
| 14 | Virtual Research Institute (WIB) – Horizon for Excellence in messenger RNA applications in immunoOncology, HERO [II] | 28 398 800 PLN (IIMCB) | 2022–2027 | Andrzej Dziembowski |
| 15 | How inactivation of Mitochondrial Calcium Uniporter protects dopaminergic neurons | 2 917 239 PLN | 2024–2028 | Jacek Kuźnicki |
| 16 | Exploring the role of Ferroportin-mediated Ca2+ influx in the functional rewiring of macrophages | 69 540 PLN | 2024–2025 | Pratik Kumar Mandal |
| 17 | The interplay between the processes of inner membrane formation and protein transport in mitochondria | 318 750 PLN | 2012–2015 | Paulina Kwiatkowska |
| 18 | Uncovering how intestinal transporter dysregulation and architectural changes contribute to malabsorption in cirrhosis | 197 884 PLN | 2026–2029 | Konstancja Gałat |
| 19 | Modeling of charge transport in RNA structural motifs | 75 000 PLN | 2013–2015 | Juliusz Stasiewicz |
POLISH ACADEMY OF SCIENCES (3)
| 1 | Polish-Spanish Special Grant – Computer prediction and simulation of RNA tertiary structure formation | 553 600 PLN | 2007–2010 | Janusz Bujnicki |
| 2 | The role of cell cortex contractility in the establishment and positioning of the cleavage furrow – MPI-CBG Junior Research Program | 3 024 200 PLN | 2006–2009 | Ewa Paluch |
| 3 | Joint MPG-PAN Junior Research Group Program | 1 500 000 EUR | 2000–2010 | Matthias Bochtler |
EU FRAMEWORK PROGRAMME (36)
| 1 | Proof of Concept – Engineered Sequence-Specific RNases: New Reagents for RNA biotechnology, eRNAses | 149 970 EUR | 2013–2013 | Janusz Bujnicki |
| 2 | Long-term, prospective study evaluating clinical and molecular biomarkers of epileptogenesis in a genetic model of epilepsy – tuberous sclerosis complex, EPISTOP | 774 818 EUR | 2013–2019 | Jacek Jaworski |
| 3 | Commercialization of the 'eRNases' technology – development of restriction enzymes for RNA | 120 000 PLN | 2014–2015 | Janusz Bujnicki |
| 4 | COST – European Epitranscriptomics Network, EPITRAN | — | 2017–2021 | Janusz Bujnicki |
| 5 | COST – Between Atom and Cell: Integrating Molecular Biophysics Approaches for Biology and Healthcare, MOBIEU | — | 2016–2020 | Krzysztof Skowronek |
| 6 | COST – Ion Channels and Immune Response toward a global understanding of immune cell physiology and for new therapeutic approaches, IONCHAN-IMMUNRESPON | — | 2015–2019 | Jacek Kuźnicki |
| 7 | Marie Curie Action Transfer of Knowledge (TOK) – Structural studies of membrane proteases, MemProt | 626 800 EUR | 2006–2010 | Matthias Bochtler |
| 8 | Integrated Project – Tracking the Endocytic Routes of Polypeptide Growth Factor Receptor Complexes and their Modulatory Role on Signalling, ENDO TRACK | 428 400 EUR | 2006–2010 | Marta Miączyńska |
| 9 | Marie Curie Action Research Training Network – A multidisciplinary approach to the study of DNA enzymes down to the single molecule level, DNA Enzymes | 254 452 EUR | 2005–2009 | Janusz Bujnicki |
| 10 | Integrated Project – From cell-cell recognition to memory formation. New strategies for the treatment of dysfunctional plasticity, learning and memory, PROMEMORIA | 478 000 EUR | 2005–2009 | Jacek Kuźnicki |
| 11 | Exgenome Molecular Enzymes, EXGENOMES | 156 000 EUR | 2011–2013 | Janusz Bujnicki |
| 12 | Initial Training Networks – Structural Biology of Membrane Proteins, SBMPs | 263 284 EUR | 2008–2012 | Sławomir Filipek |
| 13 | ERA-NET NEURON – Imaging Neurogenesis in Neurodegenerative Disease, ImageNinND | 1 085 875 PLN | 2010–2013 | Jacek Jaworski |
| 14 | Network of Excellence – European Alternative Splicing Network of Excellence, EURASNET | 143 000 EUR | 2008–2010 | Janusz Bujnicki |
| 15 | Proteins in Health and Disease, HEALTH-PROT | 954 100 EUR | 2009–2012 | Jacek Kuźnicki |
| 16 | ERC Starting Grant – Structural studies of Nucleotide Excision Repair complexes, NERCOMP | 1 498 000 EUR | 2012–2017 | Marcin Nowotny |
| 17 | ERA-NET NEURON – Novel strategies for the treatment of schizophrenia based on genetic variation of the neural cell adhesion molecule NCAM, NeuConnect | 973 080 PLN | 2011–2014 | Jacek Kuźnicki |
| 18 | Strengthening Cooperation in Molecular Biomedicine Between EU and Ukraine, COMBIOM | 973 080 EUR | 2011–2014 | Jacek Kuźnicki |
| 19 | Development of new experimental models for mental retardation and autism by iPS technology, AMREPACELL | 1 419 075 PLN | 2011–2014 | Jacek Jaworski |
| 20 | Network of Excellence – Genetic Testing in Europe, EUROGENTEST | 30 000 EUR | 2005–2010 | Michał Witt |
| 21 | Specific Targeted Research or Innovation Projects – Mechanisms of transgene integration and expression in crop plant plastids, PLASTOMICS | 164 160 EUR | 2004–2007 | Janusz Bujnicki |
| 22 | Integrated Project – Abnormal proteins in the pathogenesis of neurodegenerative disorders, APOPIS | 161 200 EUR | 2004–2006 | Jacek Kuźnicki |
| 23 | Centre of Excellence in Molecular Bio-Medicine | 350 000 EUR | 2003–2006 | Jacek Kuźnicki |
| 24 | Novel non-antibiotic treatment of staphyloccocal diseases | 238 382 EUR | 2002–2006 | Matthias Bochtler |
| 25 | Exploiting the HSP70 chaperone machine for novel therapeutic strategies in human diseases | 64 776 EUR | 2002–2004 | Maciej Żylicz |
| 26 | Continuing Education for European Biology Teachers | 23 430 EUR | 2004–2004 | Jarosław Bryk |
| 27 | Thematic Network around Cystic Fibrosis and Related Diseases | 9 600 EUR | 2002–2004 | Michał Witt |
| 28 | A new Technology for Fluorescent 'Cell Chip' Immunotoxicity Testing | 231 703 EUR | 2001–2003 | Jarosław Dastych |
| 29 | Rational engineering of lipid metabolism in flax | 149 000 EUR | 2001–2003 | Leszek Rychlewski |
| 30 | Better Experimental Screening and Treatment for Primary Ciliary Dyskinesia, BESTCILIA | 321 720 EUR | 2012–2015 | Michał Witt |
| 31 | ERC Advanced – Principles of endogenous and therapeutic mRNA turnover in vivo (ViveRNA) | 11 570 921 PLN | 2023–2028 | Andrzej Dziembowski |
| 32 | ERC Starting Grant – Breaking the code of RNA sequence-structure-function relationships, RNA+P=123D | 1 500 000 EUR | 2011–2015 | Janusz Bujnicki |
| 33 | GSK-3 in neuronal plasticity and neurodegeneration: basic mechanisms and pre-clinical assessment, NEURO.GSK3 | 280 840 EUR | 2008–2011 | Jacek Jaworski |
| 34 | Fishing for Medicines and their targets using Zebrafish models of human diseases, FishMed | 3 574 100 EUR | 2012–2016 | Jacek Kuźnicki |
| 35 | EU Joint Programme – Neurodegenerative Disease Research – Biomarkers for Alzheimer's disease and Parkinson's disease, BIOMARKAPD | 240 804 PLN | 2012–2015 | Jacek Kuźnicki |
| 36 | ERA-NET-RUS – Pathways of Store-Operated Calcium Entry (SOCE) as a novel therapeutic target in neurodegenerative diseases, TargetSoce | 134 443 EUR | 2012–2014 | Jacek Kuźnicki |
INTERNATIONAL GRANTS (25)
| 1 | International Project Grant – The role of cell cortex mechanics in cell motility | 4 692 929 PLN | 2009–2013 | Ewa Paluch |
| 2 | Excellent Institute for excellent Scientists – international promotion of the IIMCB | 99 900 PLN | 2019–2021 | Agata Skaruz |
| 3 | Identification of signals coordinating the proteolytic quality control networks [Installation Grant] | 250 000 EUR | 2018–2023 | Wojciech Pokrzywa |
| 4 | Dioscuri Centre – Laboratory of RNA-Protein Interactions | 6 642 000 PLN | 2021–2025 | Gracjan Michlewski |
| 5 | Exploring RNA folds and remote evolutionary relationships with an improved structural similarity search method | 96 000 EUR | 2022–2024 | Eugene Baulin |
| 6 | Internationalisation of the Warsaw Doctoral School in Natural and BioMedical Sciences | 2 186 700 PLN | 2022–2024 | Urszula Białek-Wyrzykowska |
| 7 | Structural and biochemical studies of UvrA DNA repair protein | 250 000 EUR | 2007–2012 | Marcin Nowotny |
| 8 | Protein biogenesis and redox homeostasis in mitochondria | 250 000 EUR | 2010–2013 | Agnieszka Chacińska |
| 9 | The Dioscuri Centre for RNA-Protein Interactions in Human Health and Disease | 2 995 000 EUR | 2021–2030 | Gracjan Michlewski |
| 10 | Sequence-structure-function relationships in the evolution of RNA and DNA methyltransferases and restriction enzymes [I] | 150 000 PLN | 2003–2005 | Janusz Bujnicki |
| 11 | Sequence-structure-function relationships in the evolution of RNA and DNA methyltransferases and restriction enzymes [II] | 78 000 USD | 2003–2005 | Janusz Bujnicki |
| 12 | Peptidases, proteases and protein degradation | 78 000 USD | 2004–2006 | Matthias Bochtler |
| 13 | Signaling from endosomes to the nucleus: The role of APPL proteins and their interacting partners | 494 500 USD | 2006–2010 | Marta Miączyńska |
| 14 | Bioinformatics-guided engineering of DNA methyltransferases | 7 000 USD | 2003–2004 | Janusz Bujnicki |
| 15 | Molecular causes underlying the partial folding of a microtubule-associated protein domain | 5 500 USD | 2003–2004 | Janusz Bujnicki |
| 16 | High-Accuracy Protein Models Derived from Lower Resolution Data | 60 000 USD | 2007–2010 | Janusz Bujnicki |
| 17 | Kinetoplastid SL RNA Biogenesis | 100 440 USD | 2004–2009 | Janusz Bujnicki |
| 18 | Low-resolution Structural Genomics of Nucleases | 53 365 USD | 2004–2006 | Janusz Bujnicki |
| 19 | Discovering New Human DNA Repair Genes by Bioinformatics | 89 401 USD | 2003–2005 | Janusz Bujnicki |
| 20 | Structural and functional studies of two members of integrase superfamily – type 2 RNase H and Ruvc resolvase | 4 106 806 PLN | 2007–2012 | Marcin Nowotny |
| 21 | Communication between intracellular organelles in trafficking and signalling: the role of APPL proteins | 4 315 706 PLN | 2005–2012 | Marta Miączyńska |
| 22 | From dynamics of bacterial RNA degradation to gene expression manipulation tools [Installation Grant] | 250 000 EUR | 2024–2029 | Ewelina Małecka-Grajek |
| 23 | Structural and Biochemical studies of Holliday junction resolution | 3 369 854 PLN | 2012–2018 | Marcin Nowotny |
| 24 | Structural and Mechanistic Studies of Nucleic Acid Processing | 715 000 USD | 2012–2017 | Marcin Nowotny |
| 25 | mTOR-driven phosphorylation of ZBP1 and Ago2 in neuronal development | 48 000 EUR | 2012–2015 | Jacek Jaworski |
FOUNDATION FOR POLISH SCIENCE (29)
| 1 | Structural and Functional Characterization of Photosystem II from Nicotiana tabacum | 326 000 PLN | 2013–2015 | Dario Piano |
| 2 | Huntingtin-associated Protein 1 Induces Store-Operated Calcium Entry by Activating IP3 Receptor Channels in Huntington's Disease | 268 333 PLN | 2014–2015 | Magdalena Czeredys |
| 3 | The role of the TET proteins in zebrafish | 280 000 PLN | 2013–2015 | Agnieszka Kolano |
| 4 | Role of S6-kinase interaction with µ-adaptin in clathrin-mediated endocytosis and its implications for pathology of tuberous sclerosis | 210 000 PLN | 2013–2015 | Anna Malik |
| 5 | Structural studies of Nucleotide Excision Repair complexes | 100 000 PLN | 2014–2016 | Marcin Nowotny |
| 6 | Functional studies on human and viral methyltransferases involved in RNA cap biosynthesis: from in silico docking and in vitro validation, to RNA methylation inhibition in human cells | 300 000 PLN | 2015–2017 | Janusz Bujnicki |
| 7 | mTOR kinase and protein sorting by retromer and trans-Golgi network | 300 000 PLN | 2015–2017 | Jacek Jaworski |
| 8 | Lead optimisation of novel antiviral drugs: influenza virus nuclease inhibitors | 80 000 PLN | 2014–2015 | Katarzyna Kamińska |
| 9 | Gene Hackers | 43 750 PLN | 2014–2015 | Anna Olchowik |
| 10 | Enzymatic chimeras with bacteriolytic activity | 100 000 PLN | 2014–2015 | Izabela Sabała |
| 11 | Role of ESCRT-I protein complex in amino acid and lipid metabolism in the context of erythropoiesis | 799 970 PLN | 2017–2018 | Jarosław Cendrowski |
| 12 | Genomics dissection of the heart pacemaker in zebrafish | 2 590 760 PLN | 2017–2020 | Cecilia Winata |
| 13 | Structural and biochemical studies of the mechanism of LINE-1 retrotransposition and hepadnaviral replication | 6 442 833,91 PLN | 2017–2022 | Marcin Nowotny |
| 14 | Cellular consequences of endosomal dysfunction for proteostasis, metabolism and cancer biology | 3 497 520 PLN | 2017–2021 | Marta Miączyńska |
| 15 | Modeling of dynamic interactions between RNA and small molecules and its practical applications | 3 449 541 PLN | 2017–2021 | Janusz Bujnicki |
| 16 | INFECTLESS – New generation of antibacterial wound dressing | 3 463 780 PLN | 2017–2021 | Izabela Sabała |
| 17 | PhD programme in Molecular Biology: Studies of nucleic acids and proteins – from basic to applied research | 2 265 421 PLN | 2010–2015 | Michał Witt |
| 18 | Biogenesis and turnover of mitochondria intermembrane space proteins | 5 940 670 PLN | 2009–2014 | Agnieszka Chacińska |
| 19 | Modeling of RNA and protein-RNA complexes: from sequence to structure to function | 2 200 000 PLN | 2010–2014 | Janusz Bujnicki |
| 20 | The interplay between epigenomics and DNA repair | 3 491 914 PLN | 2018–2023 | Matthias Bochtler |
| 21 | Molecular mechanism of dendritic arbor stability and its relation to mood disorders | 3 515 735 PLN | 2018–2023 | Jacek Jaworski |
| 22 | The regulation of methionine metabolism by the ubiquitin-proteasome system: CHIPed supervision of the methylation potential | 1 999 823 PLN | 2018–2022 | Wojciech Pokrzywa |
| 23 | Molecular Chaperones in cancer cells | 225 000 PLN | 2000–2002 | Maciej Żylicz |
| 24 | Functional interactions of human proteins involved in posttranscriptional regulatory mechanism | 4 300 000 PLN | 2016–2022 | Andrzej Dziembowski |
| 25 | Structural biology of methylation and hydroxymethylation | 2 023 940 PLN | 2011–2015 | Matthias Bochtler |
| 26 | Characterization of selected endocytic proteins as novel regulators of AP-1 mediated transcription | 430 000 PLN | 2012–2014 | Ewelina Szymańska |
| 27 | Functional characterization of the interactions between endosomal adaptor proteins APPL and Dvl proteins in the Wnt signaling pathway | 420 000 PLN | 2010–2013 | Magdalena Banach-Orłowska |
| 28 | Post-translational modifications and nuclear functions of endosomal APPL proteins | 120 000 PLN | 2007–2010 | Iwona Pilecka |
| 29 | Modeling tuberous sclerosis with induced pluripotent steam cells | 302 000 PLN | 2013–2014 | Ewa Liszewska |
NATIONAL CENTRE FOR RESEARCH AND DEVELOPMENT
| 1 | Development of new biotechnology products based on innovative technique of ribonucleic acid cleavage | 2 829 000 PLN | 2015–2018 | Janusz Bujnicki |
| 2 | Development of new cancer therapies based on selective antitumor immunomodulators | 982 500 PLN | 2015–2017 | Marcin Nowotny |
| 3 | Biocentrum Ochota – IT infrastructure for development of strategic directions of the biology and medicine | 4 834 300 PLN | 2009–2013 | Janusz Bujnicki |
| 4 | Centre of Pre-clinical Research and Technology | 14 625 545 PLN | 2008–2013 | Jacek Kuźnicki |
| 5 | Application of novel diagnostic and therapeutical methods in epilepsy and neurodevelopmental abnormalities in children based on the clinical and cellular model of mTOR dependent epilepsy | 3 088 120 PLN | 2017–2022 | Jacek Jaworski |
| 6 | Biotechnological applications of bacteriolytic protein | 2 443 260 PLN | 2013–2016 | Izabela Sabała |
| 7 | New drugs for targeted therapy of multiple myelomas | 368 880 PLN | 2012–2016 | Marcin Nowotny |
| 8 | Polish Reference Genome for Genomic Diagnostics and Personalized Medicine | 732 347 PLN | 2013–2016 | Małgorzata Mossakowska |
NATIONAL SCIENCE CENTRE
| 1 | Regulation of mTOR kinase signaling pathway by ESCRT-II complex in dendritogenesis | 140 000 PLN | 2013–2017 | Marcelina Pieprzyk |
| 2 | Bioinformatic analysis of GmrSD, a Type IV Modification-Dependent Restriction Systems | 100 000 PLN | 2013–2016 | Magdalena Machnicka |
| 3 | Role of Rap proteins in regulation of mTOR function | 1 500 000 PLN | 2013–2018 | Jacek Jaworski |
| 4 | Patient-specific iPS cells as a novel approach to study patophysiology of mTOR related neurodvelopmental disorders | 700 000 PLN | 2014–2018 | Ewa Liszewska |
| 5 | Extramitochondrial factors regulating turnover of mitochondrial intermembrane | 796 100 PLN | 2014–2017 | Piotr Brągoszewski |
| 6 | New 5-hydroxymethylcytosine binding proteins | 1 283 750 PLN | 2015–2019 | Matthias Bochtler |
| 7 | Elucidating the gene regulatory network of zebrafish heart development using genomics | 955 500 PLN | 2015–2018 | Cecilia Winata |
| 8 | Mitochondrial RNA decay and surveillance – comprehensive interdisciplinary studies | 2 953 248 PLN | 2014–2020 | Marcin Nowotny |
| 9 | Structural biology of mixed lineage leukemia proteins | 1 255 000 PLN | 2015–2019 | Matthias Bochtler |
| 10 | Modulation of mitochondrial calcium traffic in pink1 mutant Zebrafish model of Parkinson's disease | 583 437 PLN | 2015–2018 | Smijin Soman |
| 11 | Role of CacyBP/SIP in the dysregulation of beta-catenin ubiquitination in YAC128 mouse model of Huntington's disease | 650 000 PLN | 2015–2019 | Magdalena Czeredys |
| 12 | Functional Characterization of Non-Collagenous Extracellular Matrix Proteins as a Potential Molecular Target and Novel Biomarker of Liver Fibrosis | 541 875 PLN | 2015–2019 | Michał Pawlak |
| 13 | RNA structure prediction based on modeling the target sequence and homologous sequences | 49 400 PLN | 2016–2017 | Marcin Magnus |
| 14 | The role of Zebrafish mTOR in neuronal development in vivo as a key regulator of neuronal circuit formation | 689 000 PLN | 2016–2019 | Justyna Zmorzyńska |
| 15 | Modeling 3D structures and dynamics of RNA complexes with metal ions, with particular emphasis on the formation of non-canonical base pairs: extension of the SimRNA coarse-grained model towards high-resolution | 465 400 PLN | 2016–2019 | Dorota Niedziałek |
| 16 | Mechanisms protecting from oxidative damage during aging | 1 200 800 PLN | 2016–2019 | Urlike Topf |
| 17 | Identification of genes controlling brain development through genomic analysis of patients | 162 960 PLN | 2016–2020 | Cecilia Winata |
| 18 | Endocytosis of AXL receptor and its role in AXL-mediated signaling [I] | 762 929 PLN | 2016–2020 | Daria Zdżalik-Bielecka |
| 19 | Regulation of the human cap methyltransferase CMTr1 by an RNA helicase | 49 800 PLN | 2016–2017 | Magdalena Zielińska |
| 20 | Regulation of genome activity in plastids | 402 932 PLN | 2016–2017 | Andrzej Wierzbicki |
| 21 | Genomic profiling of zebrafish cardiac pacemaker cells | 921 064 PLN | 2016–2018 | Rashid Minhas |
| 22 | Deciphering BMP6 regulatory mechanisms using CRISPR/Cas9-based screening approach | 893 104 PLN | 2017–2018 | Katarzyna Mleczko-Sanecka |
| 23 | Analysis of the mitochondrial proteins translocase TIM22 in human cells | 612 000 PLN | 2016–2019 | Katarzyna Chojnacka |
| 24 | Deciphering the role of RNA editing in zebrafish development | 921 064 PLN | 2017–2018 | Leszek Pryszcz |
| 25 | Characterizing the functions and molecular mechanisms of VPS4B action in biology of colorectal cancer (CRC) cells and in CRC pathogenesis | 791 850 PLN | 2017–2020 | Ewelina Szymańska |
| 26 | The role of E3 ligase complexes in integration of protein homeostasis and aging | 1 116 875 PLN | 2017–2021 | Wojciech Pokrzywa |
| 27 | A coarse-grained method for RNA 3D structure modeling, with emphasis on noncanonical base pairing | 741 250 PLN | 2017–2021 | Michał Boniecki |
| 28 | Role of STIM2 isoforms in regulation of neuronal calcium channels in Danio rerio | 2 085 031 PLN | 2017–2021 | Jacek Kuźnicki |
| 29 | Is endocytosis disrupted in tuberous sclerosis complex? Novel studies on human neural stem cells | 100 000 PLN | 2017–2019 | Alicja Kościelny |
| 30 | The influence of surface net charge on the activity of new peptidoglycan hydrolases from Staphylococcus pettenkoferi | 47 740 PLN | 2017–2018 | Elżbieta Jagielska |
| 31 | Integrative modeling and structure determination of macromolecular complexes comprising RNA and proteins | 3 500 000 PLN | 2018–2025 | Janusz M. Bujnicki |
| 32 | Structural and mechanistic studies of bacterial DNA repair | 4 228 500 PLN | 2018–2024 | Marcin Nowotny |
| 33 | STIM proteins as new regulators of NMDA receptor trafficking in neurons | 1 999 191 PLN | 2018–2023 | Joanna Gruszczyńska-Biegała |
| 34 | Development of new methods for designing RNA molecules that fold into desired spatial structures and their use for development of new functional RNAs and for prediction of noncoding RNAs in transcriptome sequences | 1 494 250 PLN | 2018–2021 | Janusz M. Bujnicki |
| 35 | Exploring Baltic Sea cyanobacteria for small-molecule inhibitors of microRNA function | 1 410 100 PLN | 2018–2022 | Filip Stefaniak |
| 36 | The role of mu2-adaptin serine 45 and serine 309 phosphorylation in clathrin mediated endocytosis | 120 000 PLN | 2018–2021 | Aleksandra Tempes |
| 37 | Biochemical and structural studies of retroviral reverse transcriptases evolution | 1 145 000 PLN | 2017–2022 | Elżbieta Nowak |
| 38 | Finding novel determinants of the brain ventricular system | 1 294 885 PLN | 2017–2021 | Vladimir Korzh |
| 39 | mTOR kinase impact on cellular functions of selected molecular motors | 1 336 250 PLN | 2017–2020 | Jacek Jaworski |
| 40 | Uncovering the molecular mechanisms of heart regeneration in zebrafish through profiling of contributing genomic factors | 556 708 PLN | 2017–2020 | Katarzyna Nieścierowicz |
| 41 | Endocytosis of AXL receptor and its role in AXL-mediated signaling [II] | 762 929 PLN | 2016–2020 | Daria Zdżalik-Bielecka |
| 42 | Role of Tollip protein in embryonic development and protein homeostasis in the model of zebrafish (Danio rerio) | 583 750 PLN | 2017–2022 | Lidia Wolińska-Nizioł |
| 43 | Role of TBC1D5 phosphorylation in neurodevelopment and TSC-related cell pathology | 1 795 700 PLN | 2018–2022 | Jacek Jaworski |
| 44 | Photoswitchable Ligands for Riboswitches | 21 670 PLN | 2018–2019 | Filip Stefaniak |
| 45 | Approaching integrative genomics to identify molecular drivers of congenital heart disease | 1 880 050 PLN | 2019–2023 | Michał Pawlak |
| 46 | CRISPR tools for the study of embryonic development in zebrafish | 1 634 500 PLN | 2018–2023 | Matthias Bochtler |
| 47 | Bridging the gap: DNA catalysis explained | 1 247 150 PLN | 2019–2022 | Maria Almudena Ponce Salvatierra |
| 48 | Deciphering novel mechanisms that control iron sensing and iron accumulation in the liver | 1 778 635 PLN | 2019–2022 | Katarzyna Mleczko-Sanecka |
| 49 | Shedding new light on genome's dark matter: identification of novel long non-coding RNAs in zebrafish | 1 896 000 PLN | 2019–2022 | Barbara Uszczyńska-Ratajczak |
| 50 | Oncogenic mechanisms of DIS3 mutations | 3 490 750 PLN | 2017–2025 | Andrzej Dziembowski |
| 51 | Mechanism of RNA ligation in maturation of transfer RNAs | 1 985 200 PLN | 2020–2023 | Marcin Nowotny |
| 52 | Linking abnormal Ca2+ signaling and the unfolded protein response with Huntington's disease pathology in both YAC128 mouse model and iPSC-derived neurons from HD patients | 1 857 550 PLN | 2020–2024 | Magdalena Czeredys |
| 53 | Analysis of the role of cytoplasmic polyadenylation in the regulation of the innate immune response | 2 324 800 PLN | 2020–2023 | Andrzej Dziembowski |
| 54 | Reconstructing cardiovascular cell lineage evolution, one cell at a time | 2 631 552 PLN | 2020–2024 | Cecilia Winata |
| 55 | Identification of novel vulnerabilities of VPS4B-deficient cancers cells | 1 878 854 PLN | 2021–2025 | Ewelina Szymańska |
| 56 | Unraveling the influence of posttranscriptional modifications on RNA 3D structure formation and its dynamics, with the integrated use of theoretical and experimental approaches | 1 650 000 PLN | 2021–2026 | Janusz Bujnicki |
| 57 | Rac1 contribution to brain connectivity impairments and neuropsychiatric disorders in Tuberous Sclerosis Complex | 2 251 260 PLN | 2021–2025 | Justyna Zmorzyńska |
| 58 | The impact of cytoplasmic polyadenylation on local translation in neurons | 1 935 625 PLN | 2020–2023 | Andrzej Dziembowski |
| 59 | Status oksydacyjny białka STIM2 i jego partnerów interakcyjnych w mózgu myszy | 49 500 PLN | 2019–2020 | Oksana Palchevska |
| 60 | Study of the function and regulation of the key molecular chaperone UNC-45 in the development of CIM myopathy | 49 401 PLN | 2019–2021 | Małgorzata Piechota |
| 61 | Elucidating the role of TENT5C-mediated polyadenylation in erythropoiesis | 1 482 000 PLN | 2020–2024 | Monika Kusio-Kobiałka |
| 62 | Cellular adaptation to cold | 3 834 426 PLN | 2021–2024 | Wojciech Pokrzywa |
| 63 | The role of mTOR-Brg1 interaction in normal and aberrant neuronal activity | 4 092 140 PLN | 2021–2026 | Jacek Jaworski |
| 64 | Identifying unique adaptive responses of red pulp macrophages to iron deficiency [I] | 3 613 374 PLN | 2021–2026 | Katarzyna Mleczko-Sanecka |
| 65 | Identifying unique adaptive responses of red pulp macrophages to iron deficiency [II] | 3 613 374 PLN | 2021–2026 | Katarzyna Mleczko-Sanecka |
| 66 | Structural and mechanistic studies of (+)RNA virus replication | 2 684 000 PLN | 2022–2027 | Marcin Nowotny |
| 67 | Deciphering the molecular mechanism of activity switch of the ubiquitin ligase CHIP | 132 126 PLN | 2022–2025 | Pankaj Thapa |
| 68 | Building a genomic atlas of human inner ear malformations: focus on novel genes and functional non-coding regions | 845 460 PLN | 2022–2026 | Vladimir Korzh |
| 69 | A framework for de novo modeling of RNA structures using restraints derived from experimental data | 691 252 PLN | 2022–2025 | Sunandan Mukherjee |
| 70 | Adaptation of Proteins to Evade Premature Degradation by the Ubiquitin-Proteasome System | 3 686 840 PLN | 2022–2027 | Wojciech Pokrzywa |
| 71 | Dynamics of RNA degrading complexes in bacteria | 3 218 840 PLN | 2023–2028 | Ewelina Małecka-Grajek |
| 72 | Structural studies of herpesvirus proteins involved in DNA replication | 2 047 255 PLN | 2023–2027 | Małgorzata Figiel |
| 73 | Elucidating the contribution of non-coding genomic elements to heart development and disease at single-cell resolution | 3 040 240 PLN | 2023–2027 | Cecilia Winata |
| 74 | The role of gut-liver axis in Amanita species mushroom poisoning | 2 544 840 PLN | 2023–2026 | Aleksandra Kołodziejczyk |
| 75 | Targeting nucleic acid-protein complexes with small molecules using a deep-learning framework | 645 136 PLN | 2023–2026 | Ryhor Nikalayeu |
| 76 | Biological control and pharmacological regulation of RNAs implicated in aetiology of Parkinson's disease | 2 999 834 PLN | 2024–2028 | Gracjan Michlewski |
| 77 | Defining the mechanism of GSK3 dependent regulation of mTOR kinase activity in neurons in physiology and pathology | 150 000 PLN | 2011–2014 | Małgorzata Urbańska |
| 78 | The relationship between GSK3α and GSK3β activities and neuronal plasticity in chronic stress | 499 964 PLN | 2011–2014 | Iwona Cymerman |
| 79 | Characterization of mTOR-dependent phosphorylation of ZBP1 and CLIP-170 and description of its contribution to dendritic arbor development | 180 000 PLN | 2011–2014 | Anna Urbańska |
| 80 | Investigation of Arc Protein Role in Synaptic Plasticity of Hippocampal and Cortical Neurons and Mechanisms Regulating Arc Expression with the Special Focus on GSK3-Dependent Degradation | 450 000 PLN | 2011–2014 | Agata Góźdź |
| 81 | Role of transcription factor TCF7L2 in establishment of thalamocortical connectivity and identity of thalamic neurons | 96 000 PLN | 2011–2013 | Andrzej Nagalski |
| 82 | The contribution of STIM proteins and the role of store-operated calcium entry (SOCE) in calcium homeostasis of neurons | 684 000 PLN | 2011–2018 | Joanna Gruszczyńska-Biegała |
| 83 | Structural and functional characterization of novel non-coding RNAs from Helicobacter pylori | 550 000 PLN | 2011–2015 | Grzegorz Chojnowski |
| 84 | Looking for mechanisms responsible for the retinal ganglion cell loss in zebrafish stim2 knockout | 209 352 PLN | 2024–2027 | Sofiia Baranykova |
| 85 | Generation of knockouts of HMTR1 and HMTR2 genes in human somatic cells and functional analysis of cap1 and cap2 methyltransferases encoded by these genes | 100 000 PLN | 2011–2014 | Maria Werner |
| 86 | Sequence specificity and its determinants in dsRNA endoribonucleases | 350 000 PLN | 2011–2015 | Krzysztof Skowronek |
| 87 | Nuclear protein quality control in neurodegeneration | 2 514 102 PLN | 2024–2027 | Lidia Wróbel |
| 88 | The role of HSP70 in the stabilization of p53 mutants in cancer cells | 192 000 PLN | 2011–2014 | Milena Wiech |
| 89 | Decoding the molecular mechanisms behind indole-3-acetic acid's influence on liver cells | 209 960 PLN | 2025–2028 | Aleksandra Uryga |
| 90 | New functions of endocytic proteins in transcriptional regulation | 2 875 000 PLN | 2012–2018 | Marta Miączyńska |
| 91 | "Stealth" asparaginases as improved protein drugs for the treatment of childhood acute lymphoblastic leukemia (ALL) | 2 875 400 PLN | 2025–2029 | Matthias Bochtler |
| 92 | Transgenic mice with elevated basal level of calcium ions in neurons as a model of aged-induced neurodegeneration of sporadic Alzheimer's disease | 2 989 800 PLN | 2012–2019 | Jacek Kuźnicki |
| 93 | Targeting Proteinopathies: Understanding and Mitigating the Effects of Pathogenic Mutations in Cullin-RING Ubiquitin Ligase Receptor | 3 295 220 PLN | 2025–2029 | Wojciech Pokrzywa |
| 94 | Oxidation landscape of mitochondrial proteins upon ROS production and in ageing | 997 500 PLN | 2012–2016 | Agnieszka Chacińska |
| 95 | Study of functional variability of the Lactobacillus strains and their impact on hepatocytes | 49 500 PLN | 2024–2025 | Krzysztof Szczepaniak |
| 96 | Regulation of clathrin-dependent endocytosis by mTOR kinase in neuronal development | 813 125 PLN | 2012–2016 | Jacek Jaworski |
| 97 | Development of a new scoring function for models of protein-small molecule complexes and its use for studying the mechanism of protein-ligand recognition | 230 000 PLN | 2012–2015 | Irina Tuszyńska |
| 98 | Architecture and evolution of protein-RNA networks and their relevance in the process of virulence regulation | 720 000 PLN | 2012–2016 | Stanisław Dunin-Horkawicz |
| 99 | A code for RNA recognition in RNA–RRM interactions | 612 000 PLN | 2012–2016 | Martyna Nowacka |
| 100 | Does the hyperactivation of mTOR kinase interfere with cell differentiation into neurons? | 608 100 PLN | 2012–2016 | Bartosz Tarkowski |
| 101 | Structural RNomics | 3 000 000 PLN | 2012–2018 | Janusz Bujnicki |
| 102 | The hidden metabolism of food additives: microbial breakdown of azo dyes in the gut | 209 962 PLN | 2026–2029 | Natalia Rzepka |
| 103 | Destabilization of neuronal morphology in chronic inflammation: molecular mechanisms and identification of potential therapeutic agents [I] | 3 394 027 PLN | 2026–2030 | Jacek Jaworski |
| 104 | Destabilization of neuronal morphology in chronic inflammation: molecular mechanisms and identification of potential therapeutic agents [II] | 3 394 027 PLN | 2026–2030 | Jacek Jaworski |
| 105 | Structural analysis of the RNA-RNA and RNA-protein interactions | 145 000 PLN | 2012–2014 | Grzegorz Chojnowski |
| 106 | Destabilization of neuronal morphology in chronic inflammation: molecular mechanisms and identification of potential therapeutic agents [III] | 3 394 027 PLN | 2026–2030 | Jacek Jaworski |
| 107 | Subcellular localization and function of the ubiquitin-proteasome system in aging and neurodegeneration [I] | 5 892 098 PLN | 2026–2031 | Lidia Wrobel |
| 108 | Subcellular localization and function of the ubiquitin-proteasome system in aging and neurodegeneration [II] | 5 892 098 PLN | 2026–2031 | Lidia Wrobel |
| 109 | Lipid-Proteasome Interplay in Aging and Proteostasis [I] | 1 196 173 PLN | 2036–2036 | Pankaj Thapa |
| 110 | Lipid-Proteasome Interplay in Aging and Proteostasis [II] | 1 196 173 PLN | 2036–2036 | Pankaj Thapa |
| 111 | Determination of composition structure and substrate specificity of the mRNA_m6A methyltransferase protein complex | 750 000 PLN | 2012–2016 | Elżbieta Purta |
| 112 | The role of Amyloid Precursor Protein in the regulation of store-operated calcium entry | 504 000 PLN | 2012–2016 | Tomasz Węgierski |
| 113 | Identification of post-transcriptional modifications in RNA sequences through mass Spectrometry | 493 125 PLN | 2013–2014 | Bogusław Kluge |
| 114 | Analysis role of the PsbS subunit from photosystem II in the non-photochemical quenching | 99 200 PLN | 2013–2015 | Patrycja Haniewicz |
| 115 | Structural basis of the recognition of postreplicative DNA modifications | 100 000 PLN | 2013–2015 | Wojciech Siwek |
| 116 | Genome wide high throughput analysis of 5-hydroxymethyl cytosine in Danio rerio | 150 000 PLN | 2013–2017 | Karolina Mierzejewska |
| 117 | Nuclear functions of mTOR in neurons | 750 000 PLN | 2013–2016 | Jacek Jaworski |
| 118 | Interplay between MIA pathway and reactive oxygen species in mitochondrial homeostasis | 663 500 PLN | 2013–2016 | Michał Wasilewski |
| 119 | Molecular mechanisms of pro-survival processes in breast cancer | 3 000 000 PLN | 2013–2019 | Maciej Żylicz |
| 120 | Electrophysiological Profiling of Early Synaptic Dysfunction in Zebrafish Parkinson’s Disease Models | 49 940 PLN | 2026–2027 | Jacek Kuźnicki |
POLISH NATIONAL AGENCY FOR ACADEMIC EXCHANGE
| 1 | Molecular basis of enzyme specificity and applications | 2 000 000 PLN | 2018–2022 | Izabela Sabała |
| 2 | Regulation of microRNAs for the treatment and understanding the etiology of Parkinson's disease | 1 870 000 PLN | 2021–2025 | Gracjan Michlewski |
| 3 | Gut-liver axis in liver cirrhosis | 1 143 200 PLN | 2023–2026 | Aleksandra Kołodziejczyk |
MINISTRY OF SCIENCE AND HIGHER EDUCATION
| 1 | Bioinformatics search and analysis of protelomerase and its DNA recognition sites | 152 000 PLN | 2013–2014 | Łukasz Kozłowski |
| 2 | Zinc finger Com-RNA complex as an example of specific protein-RNA interaction | 200 000 PLN | 2013–2015 | Martyna Nowacka |
| 3 | mTOR complex 2 role in the regulation of actin cytoskeleton and neuronal dendritogenesis | 288 750 PLN | 2013–2015 | Małgorzata Urbańska |
| 4 | Cytosolic chaperone systems for mitochondrial precursor proteins | 3 156 000 PLN | 2014–2018 | Agnieszka Chacińska |
| 5 | Molecular determinants of sequence-specific DNA-RNA hybrid recognition | 180 000 PLN | 2013–2015 | Agata Sulej |
| 6 | Elucidating the mechanism of translational control of maternal transcripts through cytoplasmic polyadenylation | 199 980 PLN | 2015–2019 | Maciej Łapiński |
| 7 | Identification of specificity determinants of restriction endonucleases by bioinformatics and mutagenesis | 300 000 PLN | 2003–2006 | Janusz Bujnicki |
| 8 | New bioinformatic tools for proteomics and structural genomics | 1 850 000 PLN | 2004–2007 | Janusz Bujnicki |
| 9 | Analysis of sequence-structure-function relationships in the evolution of RNA methyltransferases | 19 000 PLN | 2000–2000 | Janusz Bujnicki |
| 10 | Engineering of DNA Methyltransferases | 400 000 PLN | 2000–2003 | Janusz Bujnicki |
| 11 | Characterisation of Promoter Sequences, Transcription Factors and Signal Transduction Pathways involved in the Activation of IL-4 Gene Expression by Heavy Metal Ions | 180 000 PLN | 2000–2002 | Jarosław Dastych |
| 12 | Modeling of protein structures and their complexes, A database of systems for DNA repair and degradation, Experimental analyses of DNA repair proteins | 2 009 PLN | 2006–2009 | Janusz Bujnicki |
| 13 | The Role of TNF-Alpha Propeptide in the Process of Storage of this Cytokine in Mast Cell Cytoplasmatic Granules | 20 000 PLN | 2001–2002 | Maciej Olszewski |
| 14 | Genetic and Environmental Longevity Factors in a Group of Polish Centenarians | 1 500 000 PLN | 2001–2004 | Jacek Kuźnicki |
| 15 | Modelling of G Protein-Coupled Receptor and their interactions with drugs in case of opioid receptors | 120 000 PLN | 2003–2006 | Sławomir Filipek |
| 16 | Molecular and Genetic Mechanisms of Neurodegeneration and Neuroprotection [I] | 260 000 PLN | 2001–2002 | Michał Hetman |
| 17 | Role of glycogen synthase kinase 3 beta in neuronal death | 270 000 PLN | 2001–2003 | Michał Hetman |
| 18 | Application of bioinformatic tools to characterization of enzymes involved in DNA repair | 30 800 PLN | 2003–2004 | Michał Kurowski |
| 19 | Calcium binding proteins interaction with presenilin in lymphocytes of Alzheimer's disease patients and healthy controls | 325 000 PLN | 2001–2004 | Jacek Kuźnicki |
| 20 | Molecular and Genetic Mechanisms of Neurodegeneration and Neuroprotection [II] | 300 000 PLN | 2001–2002 | Jacek Kuźnicki |
| 21 | Addiction: Neurobiological Basis, Mechanisms, Methods of Prophylaxis and Treatment | 3 400 000 PLN | 2001–2004 | Ryszard Przewłocki |
| 22 | Hsp90 in Cancerogenesis | 462 000 PLN | 2002–2005 | Alicja Wawrzynow |
| 23 | Cloning and Characterisation of a Novel Human Protein Kinase | 386 500 PLN | 2000–2003 | Lech Trzeciak |
| 24 | Influence of 3'UTR sequences of IL-4 gene on stability of mRNA | 18 200 PLN | 2000–2001 | Dominika Trzaska |
| 25 | The transduction of neuronal Ca2+-signals via EF-hand Calcium-Binding Proteins Caldendrin and Calmyrin in Alzheimer's disease and psychotic disorders | 955 400 PLN | 2003–2006 | Urszula Wojda |
| 26 | Interaction of chaperones with p53 protein | 447 000 PLN | 2000–2002 | Maciej Żylicz |
| 27 | Combating bacterial resistance against MLSb antibiotics by design of a novel type of inhibitors against Erm methyltransferases | 93 000 PLN | 2004–2006 | Marcin Feder |
| 28 | Differences in action of stress-induced and constitutively synthesized Hsp70 | 550 200 PLN | 2004–2007 | Maciej Żylicz |
| 29 | Biochemical and microscopical characterization of APPL-positive endosomes | 390 040 PLN | 2005–2008 | Marta Miączyńska |
| 30 | STRUF – the novel software for classification and prediction of proteins functions | 105 000 PLN | 2005–2007 | Joanna Sasin |
| 31 | Investigation of structure of presenilin protein and significance of its mutations in Alzheimer's disease development | 220 000 PLN | 2005–2008 | Krzysztof Jóźwiak |
| 32 | Identification of natural substrates for enzymes from the HINT family of phosphoroamidases and identification of enzymes that synthesize these substrates | 352 000 PLN | 2005–2008 | Paweł Bieganowski |
| 33 | Role of Hsp90 in regulation of gene expression involved in tumorigenic transformation | 985 000 PLN | 2004–2007 | Maciej Żylicz |
| 34 | Advanced molecular methods in haematology. Development and implementation of standardized research procedures for minimal residual disease, posttransplantation chimerism and marker translocations | 3 027 500 PLN | 2005–2009 | Michał Witt |
| 35 | Structural studies of restriction endonucleases generating unusual cleavage patterns | 160 000 PLN | 2007–2009 | Honorata Czapińska |
| 36 | Search for diagnostic methods of Alzheimer's disease and identification of pathogenic mechanisms as potential targets of therapies based on proteomic research in human lymphocytes | 400 000 PLN | 2005–2008 | Urszula Wojda |
| 37 | Mechanism of biosynthesis of unusual protein-glycosaminoglycan linkage that plays key role in inflammatory processes | 106 560 PLN | 2007–2008 | Aneta Kaczmarczyk |
| 38 | From patterns of gene expression and regulatory motifs towards prediction and modeling of global gene expression in brain physiology and pathology | 375 000 PLN | 2006–2009 | Jacek Jaworski |
| 39 | Variation of restriction enzymes sequence specificities by combination of different methods of bioinformatics and protein engineering | 278 000 PLN | 2006–2009 | Krzysztof Skowronek |
| 40 | Modelling of the structure and the process of formation of the complex of oligomeric rhodopsin and trimeric G protein | 33 200 PLN | 2006–2007 | Sławomir Filipek |
| 41 | Ageing of the Polish population – medical, psychological, sociological and economic aspects | 12 178 420 PLN | 2007–2010 | Małgorzata Mossakowska |
| 42 | Development and implementation of methods for improving protein's crystals quality by engineering of protein-protein contacts | 940 000 PLN | 2008–2011 | Janusz Bujnicki |
| 43 | Polish-German Special Grant – Relationship between dysregulated calcium homeostasis and synaptic pathology in Alzheimer's disease as a target for therapy | 1 050 000 PLN | 2007–2010 | Jacek Kuźnicki |
| 44 | Investigation of the structure of arrestin-rhodopsin complex by theoretical methods | 33 000 PLN | 2006–2007 | Sławomir Filipek |
| 45 | Novel computer programs for homology modelling and fold recognition of RNA | 240 000 PLN | 2007–2010 | Michał Boniecki |
| 46 | Proteins S-nitrosylation and Cdk5 kinase-dependent phosphorylation. Proteomic studies of synaptosomal fractions from transgenic mice – Alzheimer's disease models | 70 000 PLN | 2007–2010 | Aleksandra Szybińska |
| 47 | New tools for analysis and manipulations of nucleic acids: restriction enzymes acting on RNA and DNA-RNA hybrids | 1 000 000 PLN | 2007–2010 | Janusz Bujnicki |
| 48 | Investigation of activation processes of GPCRs by theoretical methods | 205 000 PLN | 2007–2010 | Sławomir Filipek |
| 49 | Modification of the substrate specificity of Bsp6I restriction endonuclease with novel methods of directed evolution | 50 020 PLN | 2007–2009 | Janusz Bujnicki |
| 50 | Evolutionary, structural and functional methyltransferase classification | 49 000 PLN | 2007–2009 | Janusz Bujnicki |
| 51 | Sequence-structure-function relationships in apoptotic nuclease DNase II | 30 080 PLN | 2006–2007 | Janusz Bujnicki |
| 52 | New method to predict both local and global quality of theoretical models of protein structure | 36 600 PLN | 2007–2009 | Janusz Bujnicki |
| 53 | MvaI restriction-modification system: different ways to recognize the same DNA sequence | 31 080 PLN | 2008–2009 | Matthias Bochtler |
| 54 | Role of mTOR-regulated proteins in development of dendritic tree of hippocampal and cortical neurons | 220 800 PLN | 2006–2009 | Jacek Jaworski |
| 55 | Structural and biochemical characterization of two restriction enzymes: BcnI recognizing asymmetric DNA and AvaII cutting RNA-DNA hybrids | 30 600 PLN | 2008–2009 | Matthias Bochtler |
| 56 | Studies of agonist and antagonist binding modes in opioid receptors | 50 000 PLN | 2007–2009 | Sławomir Filipek |
| 57 | Experimental characterization of the complete set of RNA methyltransferases in the model organisms and identification of their counterparts in sequenced genomes | 460 000 PLN | 2007–2010 | Janusz Bujnicki |
| 58 | Investigation of mechanisms regulating expression of calmyrin 2, a novel EF-hand Ca2+-binding protein and elucidation of calmyrin 2 role in Ca2+ signal transduction in physiology and death of neurons | 303 000 PLN | 2007–2010 | Urszula Wojda |
| 59 | Modulation of activity of transcription factors involved in tumorigenesis, by MDM2 and other E3 ubiquitin ligases | 750 000 PLN | 2008–2011 | Maciej Żylicz |
| 60 | Functional characterization of Exonuclease G – the role in the apoptosis and diabetes | 290 400 PLN | 2008–2011 | Iwona Cymerman |
| 61 | Identification and characteristics of endosomal proteins involved in the regulation of gene transcription | 340 740 PLN | 2009–2013 | Iwona Pilecka |
| 62 | Automated creation and implementation of data flow schemes between bioinformatics tools | 49 680 PLN | 2009–2011 | Janusz Bujnicki |
| 63 | Structural and biochemical studies of restriction enzymes specific for pseudopalindromic sequences | 344 400 PLN | 2008–2011 | Matthias Bochtler |
| 64 | The role of mitochondria in biogenesis and pathogenesis of superoxide dismutase Sod1 | 476 000 PLN | 2009–2012 | Agnieszka Chacińska |
| 65 | Mechanism of oncogenic activities of mutated TP53 | 600 000 PLN | 2010–2013 | Alicja Żylicz |
| 66 | Function of calmyrin 2 in Ca2+-dependent exocytosis | 60 000 PLN | 2010–2012 | Urszula Wojda |
| 67 | The role of multifunctional adaptor proteins APPL1 and APPL2 in the regulation of cell growth and tumorigenic potential | 336 000 PLN | 2010–2013 | Beata Pyrzyńska |
| 68 | Towards a new drug against influenza: Identification and characterization of compounds which abolish the activity of the influenza virus mRNA polymerase by the inhibition of virus endonuclease | 150 000 PLN | 2010–2013 | Katarzyna Kamińska |
| 69 | Biochemical and structural studies of lentiviral reverse transcriptases | 599 800 PLN | 2010–2014 | Marcin Nowotny |
| 70 | Experimental characterization of hMTcap1 and hMTcap2 – last missing enzymes taking part in biosynthesis of the cap structure of human mRNA | 500 000 PLN | 2010–2013 | Janusz Bujnicki |
| 71 | Structural studies of ββα-Me restriction endonucleases | 400 000 PLN | 2010–2012 | Honorata Czapińska |
| 72 | Identification of a genetic program regulated by Lef1/B-catenin complex in mature neurons | 372 000 PLN | 2010–2013 | Marta Wiśniewska |
| 73 | Functional analysis of proteins responsible for processing of mRNA 3' termini. Identification of domains and intrinsically disordered regions | 37 600 PLN | 2010–2012 | Janusz Bujnicki |
| 74 | Searching for Beta-catenin regulators in thalamic neurons | 48 000 PLN | 2010–2012 | Katarzyna Misztal |
| 75 | Function of STIM proteins in capacitative calcium entry to the ER of healthy neurons and of cells with calcium dyshomeostasis in Alzheimer's disease | 340 740 PLN | 2010–2013 | Jacek Kuźnicki |
| 76 | Searching for compounds abolishing bacterial resistance for MLSb antibiotics | 150 000 PLN | 2010–2011 | Elżbieta Purta |
| 77 | Is there a "universal" RNA-guided DNA endonuclease? | 400 000 PLN | 2011–2014 | Matthias Bochtler |
| 78 | The Elmo1 function regulated by mTOR kinase activity in neuronal plasticity | 250 000 PLN | 2010–2014 | Magdalena Błażejczyk |
| 79 | A new type of antibacterial drugs: a search for inhibitors of Arm methyltransferases that confer resistance to aminoglycosides | 100 000 PLN | 2010–2011 | Katarzyna Kamińska |
| 80 | Changes in cell cycle and apoptosis as a basis for diagnosis and potential therapeutic targets in Alzheimer's disease | 408 000 PLN | 2011–2014 | Urszula Wojda |
| 81 | Structural analysis of RNase H3 in complex with a substrate – the mechanism of action and substrate specificity in the context of an enzyme family | 150 000 PLN | 2012–2013 | Małgorzata Figiel |
| 82 | Development and application of new methods for protein-RNA and protein-DNA complexes modeling | 175 000 PLN | 2012–2014 | Irina Tuszyńska |
| 83 | Structural studies of mechanism of action of UvrC protein from bacterial DNA repair system called nucleotide excision repair system | 150 000 PLN | 2012–2013 | Marcin Jaciuk |
| 84 | Practical algorithms for graph isomorphism testing in the computational biology | 160 000 PLN | 2012–2014 | Tomasz Waleń |
| 85 | Casimir-Polder effect in scattering of atoms on liquid surfaces | 150 000 PLN | 2012–2013 | Grzegorz Łach |
| 86 | Coordinating proteasome subunit expression: structural biology of the master regulator Rpn4 | 400 000 PLN | 2012–2014 | Monika Sokołowska |
| 87 | Structural biology of anti-cancer DNA methyltransferase inhibitors | 200 000 PLN | 2012–2014 | Marek Wojciechowski |
| 88 | Bioinformatics analysis of sequence-structure-function relationships in the GIY-YIG nuclease superfamily | 100 000 PLN | 2012–2013 | Katarzyna Kamińska |
| 89 | Analysis of the relationship between sequence and structure in coiled-coil protein domains | 178 000 PLN | 2012–2014 | Stanisław Dunin-Horkawicz |
OPI
| 1 | Biochemical and microscopical characterization of APPL-positive endosomes | 109 000 EUR | 2006–2010 | Marta Miączyńska |
| 2 | Molecule and Cell Research Infrastructure (IBMiK) | 100 251 697 PLN | 2024–2025 | Marta Miączyńska |
MEDICAL RESEARCH AGENCY
| 1 | Mouse Genome Engineering Facility – generation of animal models for biomedical research and preclinical studies | 3 499 980 PLN | 2018–2021 | Andrzej Dziembowski |
| 2 | Identyfikacja markerów metabolicznej stłuszczeniowej choroby wątroby | 5 244 375 PLN | 2025–2026 | Aleksandra Kołodziejczyk |
OTHER
| 1 | Effective Technology Transfer in Biotechnology | 128 070 EUR | 2012–2014 | Magda Powierża |
| 2 | Summer school in Bioinformatics & NGO data analysis | 14 000 EUR | 2016–2017 | Leszek Pryszcz |
| 3 | Biocentrum Ochota – IT infrastructure for development of strategic directions of the biology and medicine | 4 834 300 PLN | 2009–2013 | Sławomir Filipek |
| 4 | ERA CHAIRS – MOlecular Signaling in Health and Disease – Interdisciplinary Centre of Excellence, MOSaIC | 2 498 887,50 EUR | 2018–2023 | Jacek Kuźnicki |
| 5 | VERTIGO STARTS: epiMimesis "Epizode V: Shifting Identities" | — | 2018–2019 | Janusz Bujnicki |
| 6 | INFRAIA – Infrastructure for transnational access and discovery in structural biology, iNEXT-Discovery | 254 166,56 PLN | 2020–2024 | Marcin Nowotny |
| 7 | Experimental analysis of molecular determinants involved in epilepsy | 1 780 590 PLN | 2021–2025 | Vladimir Korzh |
| 8 | The new methodology for better understanding of ligand-RNA interactions | 671 000 PLN | 2021–2026 | Filip Stefaniak |
| 9 | Discovery and characterization of RNA structure motifs conserved in positive-sense single-stranded RNA viruses and in other functional RNAs | 825 330 PLN | 2021–2025 | Tomasz Wirecki |
| 10 | AXL receptor signaling in cancer cell growth and drug resistance | 2 482 764 PLN | 2021–2025 | Marta Miączyńska |
| 11 | 3D Structure determination of key regulatory regions at the 5' and 3' termini of pathogenic Flaviviruses RNA | 895 358 PLN | 2021–2024 | Tales Rocha de Moura |
| 12 | Living on the edge: evolutionary adaptation of substrate-recruiting subunits of the cullin-RING ubiquitin ligase complexes to avoid premature degradation | 190 770 PLN | 2022–2025 | Natalia Szulc |
| 13 | How dysfunction in the nuclear, RNA degrading enzyme DIS3 leads to mitotic defects creating a possible therapeutic strategy for Multiple Myeloma [I] | 832 059 PLN | 2019–2022 | Tomasz Kuliński |
| 14 | EXSCALATE4COV – CORONAVIRUS-2020 – EXaSCale smArt pLatform Against paThogEns for Corona Virus | 320 602,19 PLN | 2020–2021 | Marcin Nowotny |
| 15 | ROPES – Roles of epitranscriptomics in diseases | 1 005 023,20 PLN | 2020–2025 | Janusz Bujnicki |
| 16 | Przygotowanie i złożenie do Narodowego Centrum Badań i Rozwoju wersji roboczej wniosku TEAMING pt. "RNA i Biologia Komórki – od Badań podstawowych do Terapii" o akronimie RACE [I] | 300 000 PLN | 2022–2022 | Marta Miączyńska |
| 17 | INFRASTART [I] | — | 2021–2024 | Marta Miączyńska |
| 18 | Regulation of muscle-derived exophers | 21 600 PLN | 2022–2023 | Wojciech Pokrzywa |
| 19 | INCYPRO: A key technology to enable the broad application of proteins in diagnostics and therapeutics [I] | 885 500 PLN | 2022–2025 | Janusz Bujnicki |
| 20 | Targeted single-cell gene expression analysis of mRNA vaccine response [I] | 855 871,67 PLN | 2022–2024 | Ewa Poniecka |
| 21 | INCYPRO: A key technology to enable the broad application of proteins in diagnostics and therapeutics [II] | 885 500 PLN | 2022–2025 | Janusz Bujnicki |
| 22 | Przygotowanie i złożenie do Narodowego Centrum Badań i Rozwoju wersji roboczej wniosku TEAMING pt. "RNA i Biologia Komórki – od Badań podstawowych do Terapii" o akronimie RACE [II] | 300 000 PLN | 2032–2022 | Marta Miączyńska |
| 23 | INFRASTART [II] | — | 2021–2024 | Marta Miączyńska |
| 24 | How dysfunction in the nuclear, RNA degrading enzyme DIS3 leads to mitotic defects creating a possible therapeutic strategy for Multiple Myeloma [II] | 832 059 PLN | 2019–2023 | Tomasz Kuliński |
| 25 | Targeted single-cell gene expression analysis of mRNA vaccine response [II] | 874 878,53 PLN | 2022–2025 | Ewa Poniecka |
| 26 | I stand for PROTAC – an educational computer game about protein degradation | 101 706 PLN | 2022–2024 | Wojciech Pokrzywa |
| 27 | Gut-liver axis in liver cirrhosis | 200 000 PLN | 2023–2024 | Aleksandra Kołodziejczyk |
| 28 | Regulation of microRNAs for the treatment and understanding the etiology of Parkinson's disease | 200 000 PLN | 2021–2023 | Gracjan Michlewski |
| 29 | Teaming for Excellence – RNA and Cell Biology – from Fundamental Research to Therapies (RACE) | 14 993 885 EUR | 2023–2029 | Marta Miączyńska |
| 30 | Single-molecule fluorescence analysis of the temperature dependent structure and dynamics of an RNA thermometer: consequences for its molecular function | 90 450 EUR | 2010–2013 | Janusz Bujnicki |
| 31 | Role of microbiota in progression of liver disease [Installation Grant] | 250 000 EUR | 2024–2029 | Aleksandra Kołodziejczyk |
| 32 | Aberrant synaptic plasticity in epilepsy | 362 200 EUR | 2008–2010 | Jacek Jaworski |
| 33 | Screening for novel functions of endocytic and autophagic proteins in the regulation of gene expression, cell growth and carcinogenesis | 672 572 EUR | 2010–2011 | Iwona Pilecka |
| 34 | Utrecht University fellowships for five PhD students | 40 000 EUR | 2004–2007 | Jacek Kuźnicki |
| 35 | Science of modern biology – exploratory resources for biology teachers and students | 20 000 USD | 2004–2005 | Joanna Lilpop |
| 36 | RNA and Cell Biology Platform for Research and Innovation in Medicine (RACE-PRIME) | 36 293 600 PLN | 2024–2029 | Marta Miączyńska |
| 37 | Finding molecular mechanisms behind the activation of stellate cells | 4 191 920 PLN | 2024–2028 | Aleksandra Kołodziejczyk |
| 38 | IMPRESS-U DCL: Supplement: Structure and function of plastid nucleoid | 967 180,00 PLN | 2024–2026 | Marcin Nowotny |
| 39 | Chilling resilience: Decoding phosphatases in cold adaptation | 688 080,00 PLN | 2024–2028 | Wojciech Pokrzywa |
| 40 | The role of tumor susceptibility gene in transcriptional regulation in health and disease | 6 377 591 PLN | 2012–2016 | Marta Miączyńska |
| 41 | Spatial organisation of protein quality control in neurodegenerative diseases | 250 000 EUR | 2025–2029 | Lidia Wróbel |
| 42 | TENT5A Poly(A) Polymerase: A Key Regulator in the Hypothalamus-Pituitary hormonal axis in humans | 4 806 800 PLN | 2025–2030 | Andrzej Dziembowski |
| 43 | Unravelling the Mechanisms of Gene Expression of Hepatitis A Virus | 4 778 740 PLN | 2025–2030 | Stefan Bresson |
| 44 | Design of RNA–protein interactions and complexes | 1 822 423 PLN | 2026–2028 | Janusz Bujnicki |
| 45 | RNA biology at the phage-bacteria interface | 3 287 765 PLN | 2026–2029 | Ewelina Małecka |